ISOVALERAMIDE manufacturers
- Isovaleramide
-
- $55.00
-
2026-05-11
- CAS:541-46-8
- Purity: 99.47%
- Supply Ability: 10g
- Isovaleramide
-
- $55.00
-
2026-05-11
- CAS:541-46-8
- Purity: 99.47%
- Supply Ability: 10g
- Isovaleramide
-
- $92.00
-
2025-04-30
- CAS:541-46-8
- Purity: 99.47%
- Supply Ability: 10g
|
| | ISOVALERAMIDE Basic information |
| Product Name: | ISOVALERAMIDE | | Synonyms: | ISOVALERAMIDE;beta-Methylbutyramide;isopentanamide;Isovaleric amide;isovalericacidamide;ISOVALERAMIDE 98%;Isovaleramide,98%;isopropylacetamide | | CAS: | 541-46-8 | | MF: | C5H11NO | | MW: | 101.15 | | EINECS: | 208-781-1 | | Product Categories: | RETROVIR | | Mol File: | 541-46-8.mol |  |
| | ISOVALERAMIDE Chemical Properties |
| Melting point | 135 °C | | Boiling point | 232°C | | density | 0.965 | | refractive index | 1.4367 (estimate) | | Fp | 232°C | | storage temp. | Sealed in dry,Room Temperature | | solubility | DMSO:135.0(Max Conc. mg/mL);1334.66(Max Conc. mM)
Ethanol:20.0(Max Conc. mg/mL);197.73(Max Conc. mM)
Water:20.0(Max Conc. mg/mL);197.73(Max Conc. mM) | | form | White Crystalline flakes | | pka | 16.72±0.40(Predicted) | | color | White to off-white | | Merck | 14,5230 | | BRN | 1740789 | | InChI | InChI=1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7) | | InChIKey | SANOUVWGPVYVAV-UHFFFAOYSA-N | | SMILES | C(N)(=O)CC(C)C | | CAS DataBase Reference | 541-46-8(CAS DataBase Reference) | | EPA Substance Registry System | Butanamide, 3-methyl- (541-46-8) |
| Hazard Codes | Xi | | Safety Statements | 22-24/25 | | RTECS | EJ3650000 | | TSCA | TSCA listed | | HS Code | 2924190090 |
| Provider | Language |
|
ALFA
| English |
| | ISOVALERAMIDE Usage And Synthesis |
| Uses | RT transferase inhibitor, antiviral | | in vivo | Isovaleramide (100 mg/kg, p.o., a single dose at 4-hour following fasting) evidences a 90% index protection against the maximal electroshock seizure in mice[1].
Isovaleramide (10 and 20 mg/kg, i.v.,every 12 h for 48 h) reduces the mortality rate, attenuates the pathological damage of kidney tissues in EG-poisoned rats and down-regulates the expression of serum biomarkers of AKI[2].
Isovaleramide (100 mg/kg; p.o.) shows a 90% index protection against the maximal electroshock (MES)-induced seizure in mice, comparable to Sodium phenytoin (HY-B0448A)[4].
| Animal Model: | ICR mice with electric shock induced seizures[1] | | Dosage: | 100 mg/kg | | Administration: | p.o., a single dose at 4-hour following fasting | | Result: | Evidenced a 90% index protection against the maximal electroshock seizure in mice. |
| Animal Model: | Rat model of EG poisoning[1] | | Dosage: | 10 and 20 mg/kg | | Administration: | i.v.,every 12 h for 48 h | | Result: | Effectively reduced the mortality of EG-poisoned rats, and this effect may be dose-dependent. |
|
| | ISOVALERAMIDE Preparation Products And Raw materials |
|